These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 20935457)

  • 1. Countering amyloid polymorphism and drug resistance with minimal drug cocktails.
    Duennwald ML; Shorter J
    Prion; 2010; 4(4):244-51. PubMed ID: 20935457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A synergistic small-molecule combination directly eradicates diverse prion strain structures.
    Roberts BE; Duennwald ML; Wang H; Chung C; Lopreiato NP; Sweeny EA; Knight MN; Shorter J
    Nat Chem Biol; 2009 Dec; 5(12):936-46. PubMed ID: 19915541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radically different amyloid conformations dictate the seeding specificity of a chimeric Sup35 prion.
    Foo CK; Ohhashi Y; Kelly MJ; Tanaka M; Weissman JS
    J Mol Biol; 2011 Apr; 408(1):1-8. PubMed ID: 21333653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct and selective elimination of specific prions and amyloids by 4,5-dianilinophthalimide and analogs.
    Wang H; Duennwald ML; Roberts BE; Rozeboom LM; Zhang YL; Steele AD; Krishnan R; Su LJ; Griffin D; Mukhopadhyay S; Hennessy EJ; Weigele P; Blanchard BJ; King J; Deniz AA; Buchwald SL; Ingram VM; Lindquist S; Shorter J
    Proc Natl Acad Sci U S A; 2008 May; 105(20):7159-64. PubMed ID: 18480256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prion amyloid structure explains templating: how proteins can be genes.
    Wickner RB; Shewmaker F; Edskes H; Kryndushkin D; Nemecek J; McGlinchey R; Bateman D; Winchester CL
    FEMS Yeast Res; 2010 Dec; 10(8):980-91. PubMed ID: 20726897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of cross-species prion transmission: an infectious conformation compatible with two highly divergent yeast prion proteins.
    Tanaka M; Chien P; Yonekura K; Weissman JS
    Cell; 2005 Apr; 121(1):49-62. PubMed ID: 15820678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Mechanism and application of molecular self-assembly in Sup35 prion domain of Saccharomyces cerevisiae].
    Yin W; He J; Yu Z; Wang J
    Sheng Wu Gong Cheng Xue Bao; 2011 Oct; 27(10):1401-7. PubMed ID: 22260056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct prion strains are defined by amyloid core structure and chaperone binding site dynamics.
    Frederick KK; Debelouchina GT; Kayatekin C; Dorminy T; Jacavone AC; Griffin RG; Lindquist S
    Chem Biol; 2014 Feb; 21(2):295-305. PubMed ID: 24485763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emergence and natural selection of drug-resistant prions.
    Shorter J
    Mol Biosyst; 2010 Jul; 6(7):1115-30. PubMed ID: 20422111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The physical dimensions of amyloid aggregates control their infective potential as prion particles.
    Marchante R; Beal DM; Koloteva-Levine N; Purton TJ; Tuite MF; Xue WF
    Elife; 2017 Sep; 6():. PubMed ID: 28880146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nucleation seed size determines amyloid clearance and establishes a barrier to prion appearance in yeast.
    Villali J; Dark J; Brechtel TM; Pei F; Sindi SS; Serio TR
    Nat Struct Mol Biol; 2020 Jun; 27(6):540-549. PubMed ID: 32367069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. De novo [PSI
    Sharma J; Wisniewski BT; Paulson E; Obaoye JO; Merrill SJ; Manogaran AL
    Sci Rep; 2017 Mar; 7(1):76. PubMed ID: 28250435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular basis for diversification of yeast prion strain conformation.
    Ohhashi Y; Yamaguchi Y; Kurahashi H; Kamatari YO; Sugiyama S; Uluca B; Piechatzek T; Komi Y; Shida T; Müller H; Hanashima S; Heise H; Kuwata K; Tanaka M
    Proc Natl Acad Sci U S A; 2018 Mar; 115(10):2389-2394. PubMed ID: 29467288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Site-specific structural analysis of a yeast prion strain with species-specific seeding activity.
    Marcelino-Cruz AM; Bhattacharya M; Anselmo AC; Tessier PM
    Prion; 2011; 5(3):208-14. PubMed ID: 22048721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteolysis suppresses spontaneous prion generation in yeast.
    Okamoto A; Hosoda N; Tanaka A; Newnam GP; Chernoff YO; Hoshino SI
    J Biol Chem; 2017 Dec; 292(49):20113-20124. PubMed ID: 29038292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Temperature dependence of the aggregation kinetics of Sup35 and Ure2p yeast prions.
    Sabaté R; Villar-Piqué A; Espargaró A; Ventura S
    Biomacromolecules; 2012 Feb; 13(2):474-83. PubMed ID: 22176525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Yeast Sup35 Prion Structure: Two Types, Four Parts, Many Variants.
    Dergalev AA; Alexandrov AI; Ivannikov RI; Ter-Avanesyan MD; Kushnirov VV
    Int J Mol Sci; 2019 May; 20(11):. PubMed ID: 31146333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Michler's hydrol blue elucidates structural differences in prion strains.
    Xiao Y; Rocha S; Kitts CC; Reymer A; Beke-Somfai T; Frederick KK; Nordén B
    Proc Natl Acad Sci U S A; 2020 Nov; 117(47):29677-29683. PubMed ID: 33168711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The physical basis of how prion conformations determine strain phenotypes.
    Tanaka M; Collins SR; Toyama BH; Weissman JS
    Nature; 2006 Aug; 442(7102):585-9. PubMed ID: 16810177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Hofmeister effect on amyloid formation using yeast prion protein.
    Yeh V; Broering JM; Romanyuk A; Chen B; Chernoff YO; Bommarius AS
    Protein Sci; 2010 Jan; 19(1):47-56. PubMed ID: 19890987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.